Unique Metabolomic Signature Associated with Hepatorenal Dysfunction and Mortality in Cirrhosis

The application of non-targeted metabolomic profiling has recently become a powerful non-invasive tool to discover new clinical biomarkers. This study aimed to identify metabolic pathways that could be exploited for prognostic and therapeutic purposes in hepatorenal dysfunction in cirrhosis. One hun...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Res
Prif Awduron: Mindikoglu, Ayse L., Opekun, Antone R., Putluri, Nagireddy, Devaraj, Sridevi, Sheikh-Hamad, David, Vierling, John M., Goss, John A., Rana, Abbas, Sood, Gagan K., Jalal, Prasun K., Inker, Lesley A., Mohney, Robert P., Tighiouart, Hocine, Christenson, Robert H., Dowling, Thomas C., Weir, Matthew R., Seliger, Stephen L., Hutson, William R., Howell, Charles D., Raufman, Jean-Pierre, Magder, Laurence S., Coarfa, Cristian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6037419/
https://ncbi.nlm.nih.gov/pubmed/29291380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2017.12.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg